Stay updated on Sensitivity Resistance Mediators in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sensitivity Resistance Mediators in NSCLC Clinical Trial page.

Latest updates to the Sensitivity Resistance Mediators in NSCLC Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.4.1 was added to replace v3.4.0; no study content or documents are altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoChange DetectedGlossary display was added and the footer now shows No FEAR Act Data and the revision notice (Revision: v3.4.0). These are minor UI/metadata updates and do not affect the study contents, eligibility, or results.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- Revision: v3.3.4 updated in the page footer; previously shown as v3.3.3.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded New York as a location under the Locations section, expanding recruitment sites. Removed the separate 'New York Locations' entry and the HHS Vulnerability Disclosure in the footer as part of the v3.3.3 revision.SummaryDifference0.2%

- Check74 days agoChange DetectedA minor revision from v3.2.0 to v3.3.2 appears to be a site version or UI update without changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe funding-status notice about government operating status has been removed; the page's core study details remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Sensitivity Resistance Mediators in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sensitivity Resistance Mediators in NSCLC Clinical Trial page.